Switch to Bing in English
Copilot
あなたの日常的な AI アシスタント
約 831 件の結果
  1. Natco Pharma Ltd, NATCOPHARM:NSI summary - FT.com

  2. Delhi HC bars Natco Pharma from selling cancer drug Olaparib

  3. 他の人はこちらも質問
    Natco Pharma Limited is an India-based vertically integrated, research and development (R&D)-focused pharmaceutical company. The Company is engaged in the business of pharmaceuticals, which comprises research and development, manufacturing and selling of bulk drugs and finished dosage formulations.
    Recently, a Single judge bench of the Delhi High Court, in Kudos Pharmaceuticals Ltd. v. Natco Pharma Ltd., granted an interim injunction in favour of Kudos Pharmaceuticals, restraining the defendants (Natco) from ‘manufacturing and selling, or in any manner, dealing with Olaparib, either under the brand name BRACANAT or under other brand name.
    Currency figures normalised to Natco Pharma Ltd's reporting currency: Indian Rupee INR Natco Pharma Ltd (NATCOPHARM:NSI) company profile with history, revenue, mergers & acquisitions, peer analysis, institutional shareholders and more.
    Data delayed at least 15 minutes, as of Dec 11 2023 10:18 GMT. Use our equities screener to discover other potential opportunities. Natco Pharma Limited is an India-based vertically integrated, research and development (R&D)-focused pharmaceutical company.
  4. Natco Pharma Ltd, NATCOPHARM:NSI profile - FT.com

  5. DHC’s Concerning Order in Kudos Pharmaceuticals v. Natco ...

  6. あなたの興味がありそうな検索

  7. Drug Patents and their Evergreening Conundrum - Bar and Bench

  8. NATP.M3 - | Stock Price & Latest News | Reuters

  9. Natco Pharma Ltd. Share News (NATP) - Investing.com India

  10. NATP.NS - | Stock Price & Latest News | Reuters

  11. NATP.NS - | Stock Price & Latest News | Reuters

  12. Natco Pharma Limited Share Price Today, Live NSE Stock ...

  13. あなたの興味がありそうな検索

このサイトを利用すると、分析、カスタマイズされたコンテンツ、広告に Cookie を使用することに同意したことになります。サード パーティの Cookie に関する詳細情報|Microsoft のプライバシー ポリシー